Saturna Capital Corp Merck & Co., Inc. Transaction History
Saturna Capital Corp
- $7.5 Billion
- Q3 2024
A detailed history of Saturna Capital Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Saturna Capital Corp holds 952,200 shares of MRK stock, worth $91 Million. This represents 1.44% of its overall portfolio holdings.
Number of Shares
952,200
Previous 951,032
0.12%
Holding current value
$91 Million
Previous $118 Million
8.16%
% of portfolio
1.44%
Previous 1.58%
Shares
20 transactions
Others Institutions Holding MRK
# of Institutions
3,816Shares Held
1.86BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$23.9 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.4 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.24 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.65 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $242B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...